Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Cravedi

Showing results (1-10 of 306) with videos related to

Pageof 31
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 19, 2020
FcγRIIB, a new checkpoint to halt alloreactive memory T cellsPaolo Cravedi
Kidney International|April 24, 2022
Role of cyclooxygenase-2 in macrophage subsets during kidney repairPaolo Cravedi
Current Opinion in Organ Transplantation|December 4, 2018
Editorial: New perspectives to increase transplant numbers and survivalPaolo Cravedi
Nephron|September 28, 2016
Rituximab in Membranous Nephropathy: Not All Studies Are Created EqualPaolo Cravedi
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|June 22, 2012
[Role of monoclonal antibodies in the treatment of immune-mediated kidney disease: the state of the art]Paolo Cravedi
Kidney International|March 28, 2021
Complement in membranous nephropathy: what we thought we knew and what we really knowPaolo Cravedi
Nephron|April 2, 2019
Making Procurement Biopsies Important Again for Kidney Transplant AllocationAndrea Angeletti, Paolo Cravedi
British Journal of Clinical Pharmacology|February 28, 2013
Pathophysiology of proteinuria and its value as an outcome measure in chronic kidney diseasePaolo Cravedi, Giuseppe Remuzzi
Nephron|May 21, 2019
Criteria for Living Donation from Marginal Donors: One, No One, and One Hundred ThousandChiara Cantarelli, Paolo Cravedi
Current Opinion in Organ Transplantation|July 1, 2014
The marginal kidney donorUmberto Maggiore, Paolo Cravedi
Pageof 31

Showing results (1-10 of 306) with videos related to

Sort By:
Pageof 31
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 19, 2020
FcγRIIB, a new checkpoint to halt alloreactive memory T cellsPaolo Cravedi
Kidney International|April 24, 2022
Role of cyclooxygenase-2 in macrophage subsets during kidney repairPaolo Cravedi
Current Opinion in Organ Transplantation|December 4, 2018
Editorial: New perspectives to increase transplant numbers and survivalPaolo Cravedi
Nephron|September 28, 2016
Rituximab in Membranous Nephropathy: Not All Studies Are Created EqualPaolo Cravedi
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|June 22, 2012
[Role of monoclonal antibodies in the treatment of immune-mediated kidney disease: the state of the art]Paolo Cravedi
Kidney International|March 28, 2021
Complement in membranous nephropathy: what we thought we knew and what we really knowPaolo Cravedi
Nephron|April 2, 2019
Making Procurement Biopsies Important Again for Kidney Transplant AllocationAndrea Angeletti, Paolo Cravedi
British Journal of Clinical Pharmacology|February 28, 2013
Pathophysiology of proteinuria and its value as an outcome measure in chronic kidney diseasePaolo Cravedi, Giuseppe Remuzzi
Nephron|May 21, 2019
Criteria for Living Donation from Marginal Donors: One, No One, and One Hundred ThousandChiara Cantarelli, Paolo Cravedi
Current Opinion in Organ Transplantation|July 1, 2014
The marginal kidney donorUmberto Maggiore, Paolo Cravedi
Pageof 31